These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37658934)

  • 1. The effect of canakinumab treatment on growth parameters in children with familial Mediterranean fever.
    Aydin EA; Baglan E; Kocamaz NG; Bagrul İ; Tuncez S; Ozdel S
    Clin Rheumatol; 2024 Jan; 43(1):387-392. PubMed ID: 37658934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canakinumab in Children with Familial Mediterranean Fever: A Single-Center, Retrospective Analysis.
    Kisla Ekinci RM; Balci S; Dogruel D; Altintas DU; Yilmaz M
    Paediatr Drugs; 2019 Oct; 21(5):389-395. PubMed ID: 31463794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.
    Babaoglu H; Varan O; Kucuk H; Atas N; Satis H; Salman R; Ozturk MA; Goker B; Tufan A; Haznedaroglu S
    J Clin Rheumatol; 2020 Jan; 26(1):7-13. PubMed ID: 30048391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents.
    Eroglu FK; Beşbaş N; Topaloglu R; Ozen S
    Rheumatol Int; 2015 Oct; 35(10):1733-7. PubMed ID: 26001859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canakinumab treatment in children with familial Mediterranean fever: report from a single center.
    Yazılıtaş F; Aydoğ Ö; Özlü SG; Çakıcı EK; Güngör T; Eroğlu FK; Gür G; Bülbül M
    Rheumatol Int; 2018 May; 38(5):879-885. PubMed ID: 29450637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF.
    Pinchevski-Kadir S; Gerstein M; Pleniceanu O; Yacobi Y; Vivante A; Granat OE; Spielman S; Oz RS; Tirosh I
    Pediatr Rheumatol Online J; 2023 Jan; 21(1):4. PubMed ID: 36624531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canakinumab treatment in four children with colchicine resistant familial mediterranean fever.
    Ozkan S; Atas B
    J Pak Med Assoc; 2017 Jun; 67(6):945-947. PubMed ID: 28585601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S; Dogantan S; Edeer Karaca N; Aksu G; Kutukculer N
    Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm Beneficial Effect of Canakinumab in Colchicine-resistant Familial Mediterranean Fever.
    Laskari K; Boura P; Dalekos GN; Garyfallos A; Karokis D; Pikazis D; Settas L; Skarantavos G; Tsitsami E; Sfikakis PP
    J Rheumatol; 2017 Jan; 44(1):102-109. PubMed ID: 28042127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.
    Karabulut Y; Gezer HH; Duruöz MT
    Rheumatol Int; 2022 Jan; 42(1):81-86. PubMed ID: 34550430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for reducing inflammation in familial Mediterranean fever.
    Yin X; Tian F; Wu B; Xu T
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of canakinumab withdrawal in colchicine-resistant familial Mediterranean fever.
    Sener S; Cam V; Batu ED; Kasap Cuceoglu M; Balik Z; Aliyev E; Bayindir Y; Basaran O; Bilginer Y; Ozen S
    Rheumatology (Oxford); 2023 Nov; 62(11):3700-3705. PubMed ID: 36961326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An "On Demand" canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study.
    Shehadeh K; Levinsky Y; Kagan S; Zuabi T; Tal R; Aviran NH; Butbul Aviel Y; Tirosh I; Spielman S; Miller-Barmak A; Semo Oz R; Harel L; Chodick G; Amarilyo G
    Int Immunopharmacol; 2024 May; 132():111967. PubMed ID: 38569431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study.
    Tomokawa T; Koga T; Endo Y; Michitsuji T; Kawakami A
    Mod Rheumatol; 2022 Jul; 32(4):797-802. PubMed ID: 34897516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.
    Gül A; Ozdogan H; Erer B; Ugurlu S; Kasapcopur O; Davis N; Sevgi S
    Arthritis Res Ther; 2015 Sep; 17(1):243. PubMed ID: 26337145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
    Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Parameters of Turkish Children With an Autoinflammatory Disease Before and After Canakinumab Treatment.
    Balci S; Ekinci RMK; Dogruel D; Altintas DU; Yilmaz M
    Indian Pediatr; 2020 Jul; 57(7):637-640. PubMed ID: 32727940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total Hip Joint Replacement in a Patient with Colchicine-Resistant Familial Mediterranean Fever under Canakinumab Treatment.
    Matsumoto H; Ohashi H; Fujita Y; Yoshida S; Yokose K; Temmoku J; Matsuoka N; Shinden Y; Kusano K; Sonobe T; Nakamoto Y; Yashiro-Furuya M; Asano T; Sato S; Suzuki E; Yago T; Watanabe H; Migita K
    Tohoku J Exp Med; 2022 Feb; 256(2):169-174. PubMed ID: 35236806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of colchicine and disease severity on physical growth in children with familial Mediterranean fever.
    Yoldaş TÇ; Çakar N; Başaran Ö; Acar B; Uncu N; Çaycı FŞ
    Clin Rheumatol; 2016 Jun; 35(6):1603-7. PubMed ID: 26384820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.